Type
van Brakel WH, Sihombing B, Djarir H, Beise K, Kusumawardhani L, Yulihane R, et al. Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination. Global health action [Internet]. 2012;5. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402069/pdf/GHA-5-18394.pdf
Type
Ribeiro S, Pereira H, Mangueira CL, Ferreira C, Rosseto E, Scheinberg M. The development of arthritis and antinuclear antibodies correlate with serum 25-hydroxyvitamin D levels in patients with leprosy. Annals of the rheumatic diseases. 2012;71(12):2062-3.
Type
Henriques CC, Lopéz B, Mestre T, Grima B, Panarra A, Riso N. Leprosy and rheumatoid arthritis: consequence or association?. BMJ case reports. 2012;2012.
Type
Bourée P, Carsalade G-Y. [Current status of leprosy]. La Revue du praticien. 2012;62(6):751-5.
Type
Hacker M, Sales A, Illarramendi X, Nery J, Duppre N, Bastos F, et al. A profile of patients treated at a national leprosy outpatient referral clinic in Rio de Janeiro, Brazil, 1986-2007. Revista panamericana de salud publica = Pan American journal of public health [Internet]. 2012;31(6):485-91. Available from: http://www.scielosp.org/pdf/rpsp/v31n6/v31n6a06.pdf
Type
Thai, Huong, Ba, Schurr, Truman, Alcais, et al. PARK2 Mediates Interleukin 6 and Monocyte Chemoattractant Protein 1 Production by Human Macrophages. PLoS neglected tropical diseases [Internet]. 2013;7(1):e2015. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547867/pdf/pntd.0002015.pdf
Type
Kapata N, Chanda-Kapata P, Grobusch MP, O'Grady J, Bates M, Mwaba P, et al. Leprosy trends in Zambia 1991-2009. Tropical medicine & international health : TM & IH [Internet]. 2012;17(10):1289-93. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-3156.2012.03050.x/epdf
Type
Kumar A, Girdhar A, Girdhar BK. Six months fixed duration multidrug therapy in paucibacillary leprosy: risk of relapse and disability in Agra PB cohort study. BMJ Open [Internet]. 2012;2(4):e001403. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425897/pdf/bmjopen-2012-001403.pdf
Type
Nardi SMT, Paschoal VDA, Zanetta DMT, Chiaravalloti-Neto F. [Leprosy-related disabilities after release from multidrug treatment: prevalence and spatial distribution.]. Revista de saude publica [Internet]. 2013;. Available from: http://www.scielosp.org/pdf/rsp/2013nahead/ao4048.pdf
Type
Pahan D, Oskam L, Richardus JH, Moet J, Feenstra S. Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh. Leprosy review [Internet]. 2012;83(3):292-304. Available from: http://www.lepra.org.uk/platforms/lepra/files/lr/Sept12/292.pdf